Chrystyna Bedrij Stecyk

Chrystyna Bedrij Stecyk is a Co-founder and Principal of Griffin Securities, Inc. At Griffin, Ms. Bedrij Stecyk focuses on providing business advisory services to companies and institutional investors, including investment and market analysis, strategy and development. She has over 25 years of experience in the financial services industry, including business advisory, research, and investment banking. In 2013, Ms. Bedrij Stecyk co-founded Agilis Biotherapeutics, a gene therapy company for rare diseases of the CNS that in 2018 was acquired by PTC Therapeutics, Inc. Ms. Bedrij Stecyk has a Master of Business Administration in Finance from New York University’s Leonard N. Stern of Business and a Bachelor of Arts in Economics from Vassar College. Ms. Bedrij Stecyk is registered with the Financial Industry Regulatory Authority (FINRA) and is a licensed General Securities Principal and Representative, Investment Banking Principal and Representative, Operations Professional, and Research Analyst.